News
🇪🇺 EMA Page 23Latest pharmaceutical news, drug approvals, and EMA regulatory updates
Showing 265–276 of 341 articles
Kelun-Biotech's Sac-TMT Cancer Drug Selected for Three ASCO 2026 Oral Presentations
PrescriberPoint AI Prior Authorization Platform Achieves 94.5% Clinician Acceptance Rate in Clinical Study
GRAIL's Galleri Cancer Detection Test Shows Major Results in 174,000-Patient Studies at ASCO 2026
Eupraxia Pharmaceuticals Reports Positive 36-Week Data from Highest Dose Cohort in Eosinophilic Esophagitis RESOLVE Trial
CellCarta Saves 9 Hours Weekly Using RegASK AI Platform for Regulatory Compliance
Leerink Partners Initiates Medincell Coverage with Outperform Rating Following UZEDY Risperidone LAI FDA Approvals
Getinge Receives CE Mark for Cardiohelp II ECLS System and EU MDR Approval for Intergard Synergy Vascular Graft
Karyopharm Phase 3 SENTRY Trial Results Selected for ASCO 2026 Late-Breaking Presentation in Myelofibrosis
Allogene Therapeutics Expands Cemacabtagene Ansegedleucel Phase 2 ALPHA3 Trial to South Korea and Australia
Biocon Receives Health Canada Approval for Denosumab Biosimilars Bosaya and Vevzuo
Cigna Healthcare Adds Accord BioPharma's IMULDOSA Biosimilar to Preferred Coverage Plans
BriaCell Bria-OTS+ Shows Preserved Quality of Life in Phase 3 Metastatic Breast Cancer Trial at AACR 2026